Cargando…
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
Recently we described a novel di-benzene-pyrylium-indolene (BAS00127538) inhibitor of Lipid II. BAS00127538 (1-Methyl-2,4-diphenyl-6-((1E,3E)-3-(1,3,3-trimethylindolin-2-ylidene)prop-1-en-1-yl)pyryl-1-ium) tetrafluoroborate is the first small molecule Lipid II inhibitor and is structurally distinct...
Autores principales: | Chauhan, Jamal, Cardinale, Steven, Fang, Lei, Huang, Jing, Kwasny, Steven M., Pennington, M. Ross, Basi, Kelly, diTargiani, Robert, Capacio, Benedict R., MacKerell, Alexander D., Opperman, Timothy J., Fletcher, Steven, de Leeuw, Erik P. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077133/ https://www.ncbi.nlm.nih.gov/pubmed/27776124 http://dx.doi.org/10.1371/journal.pone.0164515 |
Ejemplares similares
-
Structure–activity exploration of a small-molecule Lipid II inhibitor
por: Fletcher, Steven, et al.
Publicado: (2015) -
Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall Assembly
por: Chauhan, Jay, et al.
Publicado: (2020) -
Turning Defense into Offense: Defensin Mimetics as Novel Antibiotics Targeting Lipid II
por: Varney, Kristen M., et al.
Publicado: (2013) -
Impact of Ribosomal Modification on the Binding of the Antibiotic Telithromycin Using a Combined Grand Canonical Monte Carlo/Molecular Dynamics Simulation Approach
por: Small, Meagan C., et al.
Publicado: (2013) -
Computational Fragment-Based Binding Site Identification by Ligand Competitive Saturation
por: Guvench, Olgun, et al.
Publicado: (2009)